Drug Type Herbal medicine |
Synonyms Epimedium Prenylflavonoids Extract, Icariin, Yin Yang Huo |
Target |
Action modulators |
Mechanism AMPK modulators(AMP activated protein kinase modulators), PGC-1α modulators(Peroxisome proliferator-activated receptor gamma coactivator 1-alpha modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bipolar Disorder | Phase 3 | United States | 01 Oct 2013 | |
| Substance Abuse | Phase 3 | United States | 01 Oct 2013 | |
| Cardiovascular Diseases | Phase 1 | Singapore | 01 Oct 2016 | |
| Osteoporosis | Phase 1 | Singapore | 01 Oct 2016 | |
| Acne Vulgaris | Clinical | South Korea | 21 Mar 2023 | |
| Atrophic acne scar | Clinical | South Korea | 21 Mar 2023 | |
| Chemotherapy-induced damage | Preclinical | China | 19 May 2025 | |
| Neurodegenerative Diseases | Preclinical | China | 19 May 2025 | |
| Diabetic Cardiomyopathies | Preclinical | China | 01 May 2025 | |
| Myocardial fibrosis | Preclinical | China | 01 May 2025 |





